Metabolic implications of reduced heart-type fatty acid binding protein in insulin resistant cardiac muscle

Jane Shearer, Patrick T. Fueger, Zhi Zhang Wang, Deanna P. Bracy, David H. Wasserman, Jeffrey N. Rottman

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Insulin resistance is characterized by elevated rates of cardiac fatty acid utilization resulting in reduced efficiency and cardiomyopathy. One potential therapeutic approach is to limit the uptake and oxidation of fatty acids. The aims of this study were to determine whether a quantitative reduction in heart-type fatty acid binding protein (FABP3) normalizes cardiac substrate utilization without altering cardiac function. Transgenic (FABP3+/-) and wild-type (WT) littermates were studied following low fat (LF) or high fat (HF) diets, with HF resulting in obese, insulin-resistant mice. Cardiovascular function (systolic blood pressure, % fractional shortening) and heart dimension were measured at weaning and every month afterward for 3 mo. During this period cardiovascular function was the same independent of genotype and diet. Catheters were surgically implanted in the carotid artery and jugular vein for sampling and infusions in mice at 4 mo of age. Following 5 d recovery, mice underwent either a saline infusion or a hyperinsulinemic-euglycemic clamp (4 mU kg- 1 min- 1). Indices of long chain fatty acid and glucose utilization (Rf, Rg; μmol g wet weight- 1 min- 1) were obtained using 2-deoxy[3H]glucose and [125I]-15-ρ-iodophenyl)-3-R,S-methylpentadecanoic acid. FABP3+/- had enhanced cardiac Rg compared with WT during saline infusion in both LF and HF. FABP3+/- abrogated the HF-induced decrement in insulin-stimulated cardiac Rg. On a HF diet, FABP+/- but not WT had an increased reliance on fatty acids (Rf) during insulin stimulation. In conclusion, cardiac insulin resistance and glucose uptake is largely corrected by a reduction in FABP3 in vivo without contemporaneous deleterious effects on cardiac function.

Original languageEnglish (US)
Pages (from-to)586-592
Number of pages7
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1782
Issue number10
DOIs
StatePublished - Oct 1 2008

Fingerprint

Fatty Acid-Binding Proteins
Myocardium
Fats
Insulin
Fatty Acids
High Fat Diet
Glucose
Insulin Resistance
Blood Pressure
Glucose Clamp Technique
Jugular Veins
Weaning
Cardiomyopathies
Carotid Arteries
Catheters
Genotype
Diet
Weights and Measures
Acids

Keywords

  • Fatty acid
  • Glucose
  • Hyperinsulinemic-euglycemic clamp
  • Obesity

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology

Cite this

Metabolic implications of reduced heart-type fatty acid binding protein in insulin resistant cardiac muscle. / Shearer, Jane; Fueger, Patrick T.; Wang, Zhi Zhang; Bracy, Deanna P.; Wasserman, David H.; Rottman, Jeffrey N.

In: Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1782, No. 10, 01.10.2008, p. 586-592.

Research output: Contribution to journalArticle

Shearer, Jane ; Fueger, Patrick T. ; Wang, Zhi Zhang ; Bracy, Deanna P. ; Wasserman, David H. ; Rottman, Jeffrey N. / Metabolic implications of reduced heart-type fatty acid binding protein in insulin resistant cardiac muscle. In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 2008 ; Vol. 1782, No. 10. pp. 586-592.
@article{32f6a8921a5b45e89e0895e193009dc1,
title = "Metabolic implications of reduced heart-type fatty acid binding protein in insulin resistant cardiac muscle",
abstract = "Insulin resistance is characterized by elevated rates of cardiac fatty acid utilization resulting in reduced efficiency and cardiomyopathy. One potential therapeutic approach is to limit the uptake and oxidation of fatty acids. The aims of this study were to determine whether a quantitative reduction in heart-type fatty acid binding protein (FABP3) normalizes cardiac substrate utilization without altering cardiac function. Transgenic (FABP3+/-) and wild-type (WT) littermates were studied following low fat (LF) or high fat (HF) diets, with HF resulting in obese, insulin-resistant mice. Cardiovascular function (systolic blood pressure, {\%} fractional shortening) and heart dimension were measured at weaning and every month afterward for 3 mo. During this period cardiovascular function was the same independent of genotype and diet. Catheters were surgically implanted in the carotid artery and jugular vein for sampling and infusions in mice at 4 mo of age. Following 5 d recovery, mice underwent either a saline infusion or a hyperinsulinemic-euglycemic clamp (4 mU kg- 1 min- 1). Indices of long chain fatty acid and glucose utilization (Rf, Rg; μmol g wet weight- 1 min- 1) were obtained using 2-deoxy[3H]glucose and [125I]-15-ρ-iodophenyl)-3-R,S-methylpentadecanoic acid. FABP3+/- had enhanced cardiac Rg compared with WT during saline infusion in both LF and HF. FABP3+/- abrogated the HF-induced decrement in insulin-stimulated cardiac Rg. On a HF diet, FABP+/- but not WT had an increased reliance on fatty acids (Rf) during insulin stimulation. In conclusion, cardiac insulin resistance and glucose uptake is largely corrected by a reduction in FABP3 in vivo without contemporaneous deleterious effects on cardiac function.",
keywords = "Fatty acid, Glucose, Hyperinsulinemic-euglycemic clamp, Obesity",
author = "Jane Shearer and Fueger, {Patrick T.} and Wang, {Zhi Zhang} and Bracy, {Deanna P.} and Wasserman, {David H.} and Rottman, {Jeffrey N.}",
year = "2008",
month = "10",
day = "1",
doi = "10.1016/j.bbadis.2008.07.003",
language = "English (US)",
volume = "1782",
pages = "586--592",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "10",

}

TY - JOUR

T1 - Metabolic implications of reduced heart-type fatty acid binding protein in insulin resistant cardiac muscle

AU - Shearer, Jane

AU - Fueger, Patrick T.

AU - Wang, Zhi Zhang

AU - Bracy, Deanna P.

AU - Wasserman, David H.

AU - Rottman, Jeffrey N.

PY - 2008/10/1

Y1 - 2008/10/1

N2 - Insulin resistance is characterized by elevated rates of cardiac fatty acid utilization resulting in reduced efficiency and cardiomyopathy. One potential therapeutic approach is to limit the uptake and oxidation of fatty acids. The aims of this study were to determine whether a quantitative reduction in heart-type fatty acid binding protein (FABP3) normalizes cardiac substrate utilization without altering cardiac function. Transgenic (FABP3+/-) and wild-type (WT) littermates were studied following low fat (LF) or high fat (HF) diets, with HF resulting in obese, insulin-resistant mice. Cardiovascular function (systolic blood pressure, % fractional shortening) and heart dimension were measured at weaning and every month afterward for 3 mo. During this period cardiovascular function was the same independent of genotype and diet. Catheters were surgically implanted in the carotid artery and jugular vein for sampling and infusions in mice at 4 mo of age. Following 5 d recovery, mice underwent either a saline infusion or a hyperinsulinemic-euglycemic clamp (4 mU kg- 1 min- 1). Indices of long chain fatty acid and glucose utilization (Rf, Rg; μmol g wet weight- 1 min- 1) were obtained using 2-deoxy[3H]glucose and [125I]-15-ρ-iodophenyl)-3-R,S-methylpentadecanoic acid. FABP3+/- had enhanced cardiac Rg compared with WT during saline infusion in both LF and HF. FABP3+/- abrogated the HF-induced decrement in insulin-stimulated cardiac Rg. On a HF diet, FABP+/- but not WT had an increased reliance on fatty acids (Rf) during insulin stimulation. In conclusion, cardiac insulin resistance and glucose uptake is largely corrected by a reduction in FABP3 in vivo without contemporaneous deleterious effects on cardiac function.

AB - Insulin resistance is characterized by elevated rates of cardiac fatty acid utilization resulting in reduced efficiency and cardiomyopathy. One potential therapeutic approach is to limit the uptake and oxidation of fatty acids. The aims of this study were to determine whether a quantitative reduction in heart-type fatty acid binding protein (FABP3) normalizes cardiac substrate utilization without altering cardiac function. Transgenic (FABP3+/-) and wild-type (WT) littermates were studied following low fat (LF) or high fat (HF) diets, with HF resulting in obese, insulin-resistant mice. Cardiovascular function (systolic blood pressure, % fractional shortening) and heart dimension were measured at weaning and every month afterward for 3 mo. During this period cardiovascular function was the same independent of genotype and diet. Catheters were surgically implanted in the carotid artery and jugular vein for sampling and infusions in mice at 4 mo of age. Following 5 d recovery, mice underwent either a saline infusion or a hyperinsulinemic-euglycemic clamp (4 mU kg- 1 min- 1). Indices of long chain fatty acid and glucose utilization (Rf, Rg; μmol g wet weight- 1 min- 1) were obtained using 2-deoxy[3H]glucose and [125I]-15-ρ-iodophenyl)-3-R,S-methylpentadecanoic acid. FABP3+/- had enhanced cardiac Rg compared with WT during saline infusion in both LF and HF. FABP3+/- abrogated the HF-induced decrement in insulin-stimulated cardiac Rg. On a HF diet, FABP+/- but not WT had an increased reliance on fatty acids (Rf) during insulin stimulation. In conclusion, cardiac insulin resistance and glucose uptake is largely corrected by a reduction in FABP3 in vivo without contemporaneous deleterious effects on cardiac function.

KW - Fatty acid

KW - Glucose

KW - Hyperinsulinemic-euglycemic clamp

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=52049115140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52049115140&partnerID=8YFLogxK

U2 - 10.1016/j.bbadis.2008.07.003

DO - 10.1016/j.bbadis.2008.07.003

M3 - Article

C2 - 18692568

AN - SCOPUS:52049115140

VL - 1782

SP - 586

EP - 592

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 10

ER -